ALPHA-GALACTOSIDASE COMPOSITIONS

The present invention relates to a human ±-galactosidase protein having an N-terminal Glycine residue, wherein said human ±-galactosidase protein is translationally fused at the C-terminal to an endoplasmic reticulum retention signal peptide.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHAALTIEL, Yoseph, HANANIA, Uri, KIZHNER, Tali, SHULMAN, Avidor
Format:	Patent
Sprache:	eng ; lit
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a human ±-galactosidase protein having an N-terminal Glycine residue, wherein said human ±-galactosidase protein is translationally fused at the C-terminal to an endoplasmic reticulum retention signal peptide.